Lei Li

Lei Li


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Pharmaceutical Biology
Verified
Journal Article
Open access
YSYuanjian Song
Yuanjian Song
LQLi Qin
Li Qin
RYRongli Yang
Rongli Yang
FYFan Yang
Fan Yang
NKNwobodo Alexander Kenechukwu
Nwobodo Alexander Kenechukwu
LLLei Li
Lei Li
Context: Researchers in a variety of fields have extensively focused on histone deacetylase 6 (HDAC6) due to its aggravation of inflammatory reaction. However, relevant studies examining whether HDAC6 could exacerbate lipopolysaccharide (LPS)-induced inflammation are still lacking. Objective: We assessed the role of HDAC6 in LPS-induced brain inflammation and used the HDAC6-selective inhibitor Tubastatin A (TBSA) to investigate the potential mechanisms further. Materials and methods: Brain inflammation was induced in Kunming (KM) mice via intraperitoneal (I.P.), injection of Lipopolysaccharide (LPS) (1 mg/kg), the TBSA (0.5 mg/kg) was delivered via intraperitoneal. The phosphorylated p38 (p-p38) Mitogen-activated protein kinases (MAPK) and expression of typical inflammatory mediators, including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in both the hippocampus and cortex, were examined by immunoblotting. Nissl staining was used to detect the neuronal damage in the hippocampus and the cortex. Results: About 1 mg/kg LPS via daily intraperitoneal (I.P.) injections for 12 days significantly increased p38 MAPK phosphorylation, TNF-α and IL-6 expression, and neuronal loss. However, 0.5 mg/kg TBSA (three days before LPS treatment) by I.P. injections for 15 days could reverse the above results. Conclusions: This present study provided evidence that TBSA significantly suppressed LPS-induced neuroinflammation and the expression of p-p38. Results derived from our study might help reveal the effective targeting strategies of LPS-induced brain inflammation through inhibiting HDAC6.

10 September 2026 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
MLMing Li
Ming Li
XPXiaoyu Pan
Xiaoyu Pan
XLXi Li
Xi Li
XWXian Wu
Xian Wu
JCJiale Cai
Jiale Cai
HLHailong Lu
Hailong Lu
Background: Cardiometabolic multimorbidity (CMM) may accompany changes in cognition and everyday function in later life. We reassessed these associations across international ageing cohorts while addressing outcome structure, unequal threshold severity, measurement precision, repeated observations, mortality and non-death attrition. Methods: We harmonised repeated observations from HRS, ELSA, CHARLS, KLoSA, MHAS and SHARE. Within-interval change in a complete four-condition CMM count (hypertension, diabetes, heart disease and stroke) was used in continuous analyses, whereas transition analyses used interval-baseline CMM4. Fixed-reference, non-overlapping cognitive and functional composites were constructed by cohort. Continuous outcomes were paired cognitive and functional worsening, analysed with participant-clustered Gaussian GEE and a CMM-by-domain interaction. Binary outcomes were any cognitive and any functional transition using cohort-wave-specific thresholds targeting 20% occupancy; sensitivity analyses included 15, 25%, historical −0.43/+0.43, stricter −0.67/+0.67 and persistent-state definitions. Logistic GEE estimates were pooled using REML with Hartung-Knapp confidence intervals. Results: The data included 236,088 people, 172,518 with at least two waves, and 523,570 scheduled-wave or terminal-death intervals. In 361,562 paired intervals across six cohorts, each additional CMM condition accumulated was associated with cognitive worsening ( β = 0.0459, 95% CI 0.0243 to 0.0675; I 2 = 74.3%) and functional worsening ( β = 0.0960, 0.0809 to 0.1111; I 2 = 41.8%). The functional-minus-cognitive contrast was 0.0534 (0.0325 to 0.0742; I 2 = 51.6%). Among 266,127 intervals beginning in the distribution-defined unimpaired state, each additional baseline CMM condition was associated with any functional transition (OR = 1.33, 95% CI 1.27 to 1.40; I 2 = 64.9%) but not with a common any-cognitive transition effect (OR = 1.01, 0.95 to 1.07; I 2 = 81.8%). The functional-to-cognitive ratio of odds ratios was 1.32 (1.23 to 1.42). Persistent any-functional transition was associated with CMM (OR = 1.39, 1.33 to 1.45; I 2 = 0%), whereas persistent any-cognitive transition did not (OR = 0.99, 0.89 to 1.10; I 2 = 77.0%). Fixed reference-wave thresholds, disease-restricted exposures, cohort exclusions, KLoSA ADL-only scoring and inverse-probability weighting preserved the functional contrast. Conclusion: CMM was associated with worsening in both continuous domains, with a larger functional coefficient, and with more consistent distribution-defined functional than cognitive transitions. Associations were mainly synchronous, although a smaller delayed cognitive association was observed. Binary states are not diagnoses of mild cognitive impairment, dementia or clinical dependence; findings do not establish causality or a validated screening rule.